P. H. Gonçalves, T. S. Uldrick, and R. Yarchoan, HIV-associated Kaposi sarcoma and related 112 diseases, AIDS Lond Engl, 2017.

Y. Asahi-ozaki, Y. Sato, T. Kanno, T. Sata, and H. Katano, Quantitative analysis of Kaposi 114 sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases, J Infect Dis, vol.115, pp.773-782, 2006.

A. Marcelin, J. Motol, A. Guihot, E. Caumes, J. Viard et al., , p.117

G. Carcelain, V. Calvez, and N. Dupin, Relationship between the quantity of Kaposi 118 sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples 119 and KSHV-associated disease, J Infect Dis, vol.196, pp.1163-1166, 2007.

A. S. Laney, M. J. Cannon, H. W. Jaffe, M. K. Offermann, C. Ou et al., Human herpesvirus 8 presence and viral 122 load are associated with the progression of AIDS-associated Kaposi's sarcoma, AIDS Lond 123 Engl, vol.21, pp.1541-1545, 2007.

R. Tedeschi, M. Enbom, E. Bidoli, A. Linde, D. Paoli et al., Viral load of human 125 herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients 126 with Kaposi's sarcoma, J Clin Microbiol, vol.39, pp.4269-4273, 2001.

A. Marcelin, L. Aaron, C. Mateus, E. Gyan, I. Gorin et al., , 2003.

, Rituximab therapy for HIV-associated Castleman disease, Blood, vol.102, pp.2786-2788

I. Haq, D. Pria, A. Papanastasopoulos, P. Stegmann, K. Bradshaw et al., , p.130

M. Bower, The clinical application of plasma Kaposi sarcoma herpesvirus viral load 131 as a tumour biomarker: results from 704 patients, HIV Med, vol.17, pp.56-61, 2016.

F. Lallemand, N. Desire, W. Rozenbaum, J. C. Nicolas, and V. Marechal, Quantitative 133 analysis of human herpesvirus 8 viral load using a real-time PCR assay, J Clin Microbiol, vol.134, pp.1404-1408, 2000.

P. Purushothaman, P. Dabral, N. Gupta, R. Sarkar, and S. C. Verma, KSHV Genome 136 Replication and Maintenance, Front Microbiol, vol.7, p.54, 2016.